Literature DB >> 2157393

Pathogenicity and immunosuppressive properties of infectious bursal disease "intermediate" strains.

L A Mazariegos1, P D Lukert, J Brown.   

Abstract

This study was conducted to test the pathogenicity and immunosuppressive effects of seven commercially available infectious bursal disease (IBD) vaccines. These vaccine strains are intermediate in their pathogenicity in susceptible specific-pathogen-free (SPF) chickens. One-day-old and 3-week-old SPF chickens were vaccinated with these vaccines. Two weeks after IBD vaccination, they were vaccinated with Newcastle disease virus (NDV). The pathogenic and immunosuppressive effects of the IBD vaccines were evaluated by the antibody response to NDV vaccination, the bursa: body weight index, and histopathological lesions of the bursa. It was found that these strains were highly variable in their virulence and immunosuppressive properties. Three of the strains tested were found to be highly virulent and immunosuppressive; two others were moderate; and two could be classified as mild.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2157393

Source DB:  PubMed          Journal:  Avian Dis        ISSN： 0005-2086            Impact factor:   1.577


  10 in total

1.  Immune responses to intermediate strain IBD vaccine at different levels of maternal antibody in broiler chickens.

Authors:  K Kumar; K C Singh; C B Prasad
Journal:  Trop Anim Health Prod       Date:  2000-12       Impact factor: 1.559

2.  Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens.

Authors:  K Tsukamoto; S Saito; S Saeki; T Sato; N Tanimura; T Isobe; M Mase; T Imada; N Yuasa; S Yamaguchi
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

3.  The characterization of infectious bursal disease virus strains/isolates from field outbreaks in India.

Authors:  B Pahar; A Rai
Journal:  Vet Res Commun       Date:  1997-05       Impact factor: 2.459

4.  Pathogenicity and immunosuppressive properties of infectious bursal disease virus field isolates and commercial vaccines in India.

Authors:  A Thangavelu; G D Raj; S Elankumaran; B M Manohar; A Koteeswaran; A T Venugopalan
Journal:  Trop Anim Health Prod       Date:  1998-06       Impact factor: 1.559

5.  Consequence of Cryptosporidiosis on the immune response of vaccinated broiler chickens against Newcastle disease and/or avian influenza.

Authors:  Abdelfattah H Eladl; Hamed R Hamed; Mostafa R Khalil
Journal:  Vet Res Commun       Date:  2014-07-05       Impact factor: 2.459

6.  Comparison of two attenuated infectious bursal disease vaccine strains focused on safety and antibody response in commercial broilers.

Authors:  Thotsapol Thomrongsuwannakij; Nataya Charoenvisal; Niwat Chansiripornchai
Journal:  Vet World       Date:  2021-01-11

7.  A Single Vaccination of IBDV Subviral Particles Generated by Kluyveromyces marxianus Efficiently Protects Chickens against Novel Variant and Classical IBDV Strains.

Authors:  Deqiang Yang; Lixia Zhang; Jinkun Duan; Qiang Huang; Yao Yu; Jungang Zhou; Hong Lu
Journal:  Vaccines (Basel)       Date:  2021-12-07

8.  Epidemiology and laboratory diagnosis of very virulent infectious bursal disease virus in vaccinated chickens in Khartoum, Sudan.

Authors:  Mohammed Gasim Omer; Abdelmalik Ibrahim Khalafalla
Journal:  Open Vet J       Date:  2022-01-09

9.  Isolation of Infectious Bursal Disease Virus Using Indigenous Chicken Embryos in Kenya.

Authors:  W U Mutinda; L W Njagi; P N Nyaga; L C Bebora; P G Mbuthia; D Kemboi; J W K Githinji; A Muriuki
Journal:  Int Sch Res Notices       Date:  2015-11-23

10.  Development of a Novel Assay Based on Plant-Produced Infectious Bursal Disease Virus VP3 for the Differentiation of Infected From Vaccinated Animals.

Authors:  Alessio Bortolami; Marcello Donini; Carla Marusic; Chiara Lico; Charifa Drissi Touzani; Federica Gobbo; Elisa Mazzacan; Andrea Fortin; Valentina Maria Panzarin; Francesco Bonfante; Selene Baschieri; Calogero Terregino
Journal:  Front Plant Sci       Date:  2021-12-07       Impact factor: 5.753
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.